menu
event

Capturing Continuous Glucose Monitoring Advantages

Register now

June 28, 2017

Register Save to Calendar

 

Summary

With increasing pricing pressures in a therapeutic area which has seen many recent drug approvals, diabetes drug developers are seeking to enhance their clinical development and portfolio. By leveraging Continuous Glucose Monitoring (CGM), sponsors conducting trails in diabetes as well as other indications have the potential to enhance patient safety, accelerate clinical development and increase commercial value.

Attend this live webinar to hear QuintilesIMS, in collaboration with key CGM opinion leaders, discuss the advantages of using CGM in your clinical trials.

Register for this webinar to learn:

  • Expert insights from QuintilesIMS’s Diabetes Center of Excellence
  • Firsthand case studies on how using CGM devices can help increase commercial value
  • Opportunities for CGM to accelerate clinical trials

Register today to understand how CGM captures near real-time glycemic data that can help enhance patient safety, accelerate clinical development and increase commercial value.

Speakers

Erica Caveney, MD
Vice President, Global Head, Diabetes Center of Excellence
QuintilesIMS

James R. Johnson, PhD
Principle Biostatistician and Pharmacokineticist
Summit Analytical

Poul Strange, MD, PhD
President and Medical Director
Integrated Medical Development